Predicting prevalence and severity of cytokine release syndrome after CAR T-cell therapy in patients with autoimmune disease: a retrospective cohort study
Predicting prevalence and severity of cytokine release syndrome after CAR T-cell therapy in patients with autoimmune disease: a retrospective cohort study. // The Lancet Rheumatology. – URL: https://www.sciencedirect.com/science/article/pii/S2665991326002304?dgcid=rss_sd_all
Predicting prevalence and severity of cytokine release syndrome after CAR T-cell therapy in patients with autoimmune disease: a retrospective cohort study. The Lancet Rheumatology. https://www.sciencedirect.com/science/article/pii/S2665991326002304?dgcid=rss_sd_all
“Predicting prevalence and severity of cytokine release syndrome after CAR T-cell therapy in patients with autoimmune disease: a retrospective cohort study.” The Lancet Rheumatology.
@article{article69297,
title = {Predicting prevalence and severity of cytokine release syndrome after CAR T-cell therapy in patients with autoimmune disease: a retrospective cohort study},
journal = {The Lancet Rheumatology},
url = {https://www.sciencedirect.com/science/article/pii/S2665991326002304?dgcid=rss_sd_all}
}